Tagged with

Opinion Pierre Meulien of the Innovative Medicines Initiative (IMI) discusses the potential impact that new technological innovations will have on the drug development process.   A more technologically integrated approach is required that looks more holistically at the patient as an individual Whether we call it “Personalised”, “Precision”, “Stratified”, or “Tailored”, the age…

Sweden Over EUR 1 billion was spent in Sweden on pharmaceutical R&D in 2015, a similar level to spending seen in Italy and Denmark. Made with Visme Infographic Maker   Sweden is playing host to a growing number of clinical trials. The number of projects in clinical development in Sweden more…

Sweden The size of the Swedish pharma market is dwarfed by those of the EU5, but Sweden does host the largest market in the Nordics region, ahead of  Denmark, Finland and Norway. Made with Visme Infographic Maker   Sweden produced over EUR 7 billion worth of pharmaceuticals in 2015, a considerable…

Taiwan As part of its ‘Asia Silicon Valley Development Plan’, Taiwan has designated a special focus to each of its regions. The Taiwanese government is aiming to develop a new economic model and make Taiwan, “the stage for innovation talent in Asia and example of innovation and entrepreneurship, with the goal…

Sweden Cardiovascular diseases are the leading cause of death among both men and women in Sweden, followed by cancer and diseases of the nervous system.   Made with Visme Infographic Maker  

Korea One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation. As the Korean state shifts its focus towards healthcare and the life sciences and Korean firms begin to internationalize with greater…

Spain Alba Vergés, Minister of Health of Catalonia, highlights her key priorities within the thriving region of Catalonia as well as the factors that have created a unique ecosystem. Furthermore, she highlights the department’s relationship with the pharmaceutical industry and the need to think about sustainability in today’s healthcare environment.  …

Egypt Ashraf Elkhouly, executive director of the Egyptian Society for Pharmaceutical Research, discusses how recent healthcare reforms will help to attract more investment to Egypt and the importance of public-private partnerships for improving the country’s healthcare system.   In collaboration with the government, we started to look into possibilities on how…

Spain Lab Seid is a family owned pharmaceutical company based in Barcelona, specialising in branded out of patent products in the field of women’s health. Seid’s general manager, Joaquín Vilá, discusses the turnaround of the company since taking over in 2011, and the strategy behind its consolidation around gynaecology. Vila also…

Egypt Ahmed Elfangary, country manager of DHL Express Egypt, highlights the company’s leadership position in the Egyptian logistics field, while aiming to be a strong partner of the government. He also explains how DHL is a partner of choice in the healthcare and life sciences field and his ambition to make…

Europe From her vantage point as associate vice president for MSD’s Central & Eastern Europe (CEE) cluster, Gabriele Grom outlines the disparity that still exists in terms of access to cancer treatments across Europe and what must be done to bridge this gap.   Despite the existence of innovative treatments, cancer…

Korea The Korean cosmetics market is now the 8th largest in the world, with 2.9 percent of the global market share, capitalising on the global rise in interest for Korean culture, a phenomenon known as ‘Hallyu’ – ‘the Korean wave’. “In the past, Korean cosmetics had lower product quality and brand…